These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


588 related items for PubMed ID: 28673534

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Discordance of intraoperative frozen section analysis with definitive histology of sentinel lymph nodes in breast cancer surgery: complementary axillary lymph node dissection is irrelevant for subsequent systemic therapy.
    Geertsema D, Gobardhan PD, Madsen EV, Albregts M, van Gorp J, de Hooge P, van Dalen T.
    Ann Surg Oncol; 2010 Oct; 17(10):2690-5. PubMed ID: 20422461
    [Abstract] [Full Text] [Related]

  • 5. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
    Kuru B, Yuruker S, Sullu Y, Gursel B, Ozen N.
    J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy.
    Pride RM, Glass CC, Nakhlis F, Laws A, Weiss AC, Bellon JR, Mittendorf EA, King TA, Kantor O.
    Ann Surg Oncol; 2023 Oct; 30(10):5978-5987. PubMed ID: 37436607
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
    Moo TA, Edelweiss M, Hajiyeva S, Stempel M, Raiss M, Zabor EC, Barrio A, Morrow M.
    Ann Surg Oncol; 2018 Jun; 25(6):1488-1494. PubMed ID: 29572705
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R, Peintinger F, Rettenbacher L, Prokop E.
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer.
    Ozkurt E, Yardımcı E, Tükenmez M, Ersoy YE, Yilmaz R, Cabioğlu N, Karanlık H, Kulle CB, Malya FU, Önder S, Gucin Z, İğci A, Özmen V, Dinççağ AS, Müslümanoğlu M.
    Breast J; 2019 Jan; 25(1):96-102. PubMed ID: 30419607
    [Abstract] [Full Text] [Related]

  • 15. Effect of T Stages on the Choice of Axillary Evaluation Modality in Breast Cancer Patients With 1-2 Sentinel Lymph Node Metastases.
    Liu D, Chang L, Zhao X, Dai L, Cui H, Liu P, Zhai Z, Wu H, Ma X, Kang H.
    Clin Breast Cancer; 2024 Jun; 24(4):e232-e243.e1. PubMed ID: 38368246
    [Abstract] [Full Text] [Related]

  • 16. Can Axillary Lymph Node Dissection be Omitted in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes Undergoing Mastectomy? A Systematic Review and Meta-Analysis of Real-World Evidence.
    Chen F, Li X, Lin X, Chen L, Lin Z, Wu H, Chen J.
    World J Surg; 2023 Oct; 47(10):2446-2456. PubMed ID: 37249632
    [Abstract] [Full Text] [Related]

  • 17. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
    Classe JM, Loaec C, Gimbergues P, Alran S, de Lara CT, Dupre PF, Rouzier R, Faure C, Paillocher N, Chauvet MP, Houvenaeghel G, Gutowski M, De Blay P, Verhaeghe JL, Barranger E, Lefebvre C, Ngo C, Ferron G, Palpacuer C, Campion L.
    Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Laws A, Hughes ME, Hu J, Barry WT, Dominici L, Nakhlis F, Barbie T, Duggan M, Weiss A, Rhei E, Carter K, Nimbkar S, Schnitt SJ, King TA.
    Ann Surg Oncol; 2019 Nov; 26(12):3846-3855. PubMed ID: 31222687
    [Abstract] [Full Text] [Related]

  • 20. Synergy of cytological methods in the pathological staging of breast cancer: Axillary fine-needle aspiration and intraoperative scrape cytology of the sentinel lymph node.
    Bruzzone M, Saro F, Bruno S, Celiento T, Mazzarella G, Lanata S, Aquilano MC, Parmigiani G, Pollone M, Gandolfo F, Costigliolo G, Sironi M.
    Diagn Cytopathol; 2018 Nov; 46(11):919-926. PubMed ID: 30353679
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.